The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis
Background Thrombocytopenia is a common problem in the management of patients with cancer and other conditions that affect hematopoietic cells. In previous clinical trials, the polyethylene-glycol-conjugated recombinant human megakaryocyte growth and development factor increased platelet counts in p...
| 出版年: | Haematologica |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Ferrata Storti Foundation
2008-10-01
|
| オンライン・アクセス: | https://haematologica.org/article/view/5031 |
